Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria. - Wikidata - awgldk - TriplyDB

Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.

Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.

http://www.wikidata.org/entity/Q37017209

about

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.Use of immune modulators in nonspecific therapy of bacterial infections.Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes.Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection.Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli.Influence of immunoglobulin and interleukin 2 on the translocation of microorganisms from gut into blood

P2860

Q24654068-0CECFD21-F300-4E9A-8D00-C72D018EFE2E Q35904500-28109E78-A72C-4EBA-AE53-154E4DCF22C5 Q36133627-79047CE5-2BE6-4C41-BF71-4E67F024B24A Q36992371-F93F247A-E27A-46AA-B315-A3A39AF380E8 Q36998998-F0F4C630-D05D-4327-B49F-7B4C0DB07ADD Q37024825-47F81E02-A324-4D2D-94FA-688600AD6B64 Q40146179-2C0A35BB-A176-46FB-95E5-433346F4C1AC Q40150624-30BE0679-112A-4026-8178-A602FE4EE896 Q42186243-BBE8E724-1E62-4805-B166-7A5C0D9C3E8A

P2860

Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.

http://www.wikidata.org/entity/Q37017209

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 1987

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prophylactic administration of ...... e with gram-negative bacteria.

@en

Prophylactic administration of ...... e with gram-negative bacteria.

@nl

type

label

Prophylactic administration of ...... e with gram-negative bacteria.

@en

Prophylactic administration of ...... e with gram-negative bacteria.

@nl

prefLabel

Prophylactic administration of ...... e with gram-negative bacteria.

@en

Prophylactic administration of ...... e with gram-negative bacteria.

@nl

P1433

Q37017209-5C2B8A14-C693-4B27-89CA-AA396C9BE0C6

P1476

Q37017209-D7397E3E-BAA2-431B-A422-511F6DF6E98B

P2093

Q37017209-10EE93E5-8B0D-4AD2-84AC-FFE3E5E817EB

P2860

Q37017209-0983B2CE-3990-4799-B1C9-4558F73EDBB7

Q37017209-0CF37C70-91A8-478A-954D-C6894EE76DC8

Q37017209-15FAE148-393C-452E-84E4-9E4FCE50A3C2

Q37017209-254C9113-AC43-40C7-9CC8-3531419BC913

Q37017209-2ADD1C02-61BF-4C38-9FA6-9E858F39A634

Q37017209-30AC3780-E38D-453C-B1C1-BDAB78581A3A

Q37017209-39F50088-5800-4A01-8F44-034322A65FD2

Q37017209-4793DC7C-7584-42E0-9E23-C3596777D155

Q37017209-5C9D706A-FE2D-432B-B678-321DCFE6989A

Q37017209-6958D8EF-35EE-4B7D-8002-1484541DF369

P304

Q37017209-D52EC809-AC2F-45B6-A9CA-BF9DD77FE0C9

P31

Q37017209-2530E098-2822-44E9-BD2C-3D18FC4F9DF6

P407

Q37017209-E4E7A587-3CA7-4374-AA94-D6BBC75840BC

P433

Q37017209-F4F27110-9FBB-48C3-A459-E4FF485CD58F

P478

Q37017209-A66CBDB4-826A-439E-8221-E231B6E7B0B3

P577

Q37017209-32591D6A-25D8-4D51-8BBD-CF7B063BF892

P698

Q37017209-0AC32CC5-F214-4523-9466-D124F9D2966D

P921

Q37017209-3F0D7757-CCA0-424E-9E8A-97CB54BFD176

Q37017209-696c36d2-60da-4ae4-bdaf-36648af4a565

P932

Q37017209-606BCA12-3F6C-4907-BCF9-7779D5C303CB

P1433

Infection and Immunity

P1476

Prophylactic administration of ...... ge with gram-negative bacteria

@en

P2093

Chong KT

http://www.w3.org/2001/XMLSchema#string

P2860

Defective T-cell response in beige mutant mice

Spectrum and possible mechanism of carrageenan cytotoxicity.

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Expression of interleukin 2 receptors on activated human B cells

Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.

In vitro kinetics of phagocytosis and intracellular killing of gonococci by peritoneal macrophages from mice deficient in complement component 5

Phagocytic and chemiluminescent responses of mouse peritoneal macrophages to living and killed Salmonella typhimurium and other bacteria.

Determinants of infection in the peritoneal cavity. I. Response to and fate of Staphylococcus aureus and Staphylococcus albus in the mouse.

Antimicrobial activity of various immunomodulators: independence from normal levels of circulating monocytes and natural killer cells.

Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease

P304

668-673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

1987-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3546134

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

P932

260391

http://www.w3.org/2001/XMLSchema#string